These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
717 related articles for article (PubMed ID: 14727923)
41. Dietary administration of sodium arsenite to rats: relations between dose and urinary concentrations of methylated and thio-metabolites and effects on the rat urinary bladder epithelium. Suzuki S; Arnold LL; Pennington KL; Chen B; Naranmandura H; Le XC; Cohen SM Toxicol Appl Pharmacol; 2010 Apr; 244(2):99-105. PubMed ID: 20045014 [TBL] [Abstract][Full Text] [Related]
42. Dimethylthioarsenicals as arsenic metabolites and their chemical preparations. Suzuki KT; Mandal BK; Katagiri A; Sakuma Y; Kawakami A; Ogra Y; Yamaguchi K; Sei Y; Yamanaka K; Anzai K; Ohmichi M; Takayama H; Aimi N Chem Res Toxicol; 2004 Jul; 17(7):914-21. PubMed ID: 15257616 [TBL] [Abstract][Full Text] [Related]
43. Methylated trivalent arsenicals as candidate ultimate genotoxic forms of arsenic: induction of chromosomal mutations but not gene mutations. Kligerman AD; Doerr CL; Tennant AH; Harrington-Brock K; Allen JW; Winkfield E; Poorman-Allen P; Kundu B; Funasaka K; Roop BC; Mass MJ; DeMarini DM Environ Mol Mutagen; 2003; 42(3):192-205. PubMed ID: 14556226 [TBL] [Abstract][Full Text] [Related]
44. Intra-individual variation in the metabolism of inorganic arsenic. Concha G; Vogler G; Nermell B; Vahter M Int Arch Occup Environ Health; 2002 Oct; 75(8):576-80. PubMed ID: 12373320 [TBL] [Abstract][Full Text] [Related]
45. Pharmacokinetics of intravenous arsenic trioxide in the treatment of acute promyelocytic leukemia. Ni J; Chen G; Shen Z; Li X; Liu H; Huang Y; Fang Z; Chen S; Wang Z; Chen Z Chin Med J (Engl); 1998 Dec; 111(12):1107-10. PubMed ID: 11263375 [TBL] [Abstract][Full Text] [Related]
46. Interaction of trivalent arsenicals with metallothionein. Jiang G; Gong Z; Li XF; Cullen WR; Le XC Chem Res Toxicol; 2003 Jul; 16(7):873-80. PubMed ID: 12870890 [TBL] [Abstract][Full Text] [Related]
47. Effect of plasma homocysteine level and urinary monomethylarsonic acid on the risk of arsenic-associated carotid atherosclerosis. Wu MM; Chiou HY; Hsueh YM; Hong CT; Su CL; Chang SF; Huang WL; Wang HT; Wang YH; Hsieh YC; Chen CJ Toxicol Appl Pharmacol; 2006 Oct; 216(1):168-75. PubMed ID: 16806340 [TBL] [Abstract][Full Text] [Related]
48. Arsenic in the cerebrospinal fluid of a patient receiving arsenic trioxide for relapsed acute promyelocytic leukemia with CNS involvement. Knipp S; Gattermann N; Schapira M; Käferstein H; Germing U Leuk Res; 2007 Nov; 31(11):1585-7. PubMed ID: 17416415 [TBL] [Abstract][Full Text] [Related]
49. Speciation of arsenic trioxide metabolites in blood cells and plasma of a patient with acute promyelocytic leukemia. Yoshino Y; Yuan B; Miyashita SI; Iriyama N; Horikoshi A; Shikino O; Toyoda H; Kaise T Anal Bioanal Chem; 2009 Jan; 393(2):689-97. PubMed ID: 19009285 [TBL] [Abstract][Full Text] [Related]
51. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Tseng CH; Huang YK; Huang YL; Chung CJ; Yang MH; Chen CJ; Hsueh YM Toxicol Appl Pharmacol; 2005 Aug; 206(3):299-308. PubMed ID: 16039941 [TBL] [Abstract][Full Text] [Related]
52. Metabolic differences between two dimethylthioarsenicals in rats. Suzuki KT; Iwata K; Naranmandura H; Suzuki N Toxicol Appl Pharmacol; 2007 Jan; 218(2):166-73. PubMed ID: 17174369 [TBL] [Abstract][Full Text] [Related]
53. Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India. Mandal BK; Ogra Y; Suzuki KT Chem Res Toxicol; 2001 Apr; 14(4):371-8. PubMed ID: 11304125 [TBL] [Abstract][Full Text] [Related]
54. Arsenic speciation based on ion exchange high-performance liquid chromatography hyphenated with hydride generation atomic fluorescence and on-line UV photo oxidation. He B; Jiang GB; Xu X Fresenius J Anal Chem; 2000 Dec; 368(8):803-8. PubMed ID: 11227567 [TBL] [Abstract][Full Text] [Related]
55. Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in mice following acute oral administration of arsenate. Kenyon EM; Del Razo LM; Hughes MF Toxicol Sci; 2005 May; 85(1):468-75. PubMed ID: 15703264 [TBL] [Abstract][Full Text] [Related]
56. Stability of arsenic metabolites, arsenic triglutathione [As(GS)3] and methylarsenic diglutathione [CH3As(GS)2], in rat bile. Kobayashi Y; Cui X; Hirano S Toxicology; 2005 Jul; 211(1-2):115-23. PubMed ID: 15863254 [TBL] [Abstract][Full Text] [Related]